Back to Trades
Sensenig Bethany
DirectorCIK 0001899935
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 10
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 4
- Active
- 2025–2026
Sensenig Bethany, Director, has filed 10 SEC reports (2025–2026), spread across 4 companies, totaling $4.5M in disclosed volume. Weighing $0 bought versus $455.1K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
10 loaded
| Nov 4 | SUPN Supernus, Inc. | Sensenig Bethany | Director | Other | $1.5M |
| Nov 4 | SUPN Supernus, Inc. | Sensenig Bethany | Director | Other | $0 |
| Nov 4 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sensenig Bethany | Director | Other | $1.5M |
| Jun 11 | KALV KalVista Pharmaceuticals, Inc. | Sensenig Bethany | Insider | Disposed | $542.3K |
| Apr 17 | ACOG Alpha Cognition Inc. | Sensenig Bethany | Insider | Grant | $46.5K |
| Apr 17 | ACOG Alpha Cognition Inc. | Sensenig Bethany | Insider | Other | $0 |
| Feb 23 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sensenig Bethany | Director | Sell | $228.3K |
| Oct 2 | KALV KalVista Pharmaceuticals, Inc. | Sensenig Bethany | Insider | Award | $542.3K |
| Oct 2 | KALV KalVista Pharmaceuticals, Inc. | Sensenig Bethany | Insider | Other | $0 |
| Aug 18 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Sensenig Bethany | Director | Sell | $226.8K |
10 filings